The antimicrobial peptide cathelicidin is critical for the development of Th17 responses in severe inflammatory disease (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2022.01.27.477976
Publication URI: http://dx.doi.org/10.1101/2022.01.27.477976
Type: Preprint